Concepedia

Satish Vedi

SV

Statistics

Publications

12

Citations

240

H-Index

11

Active since

2005

Affiliations

Central Drug Research Institute(Current)

University of Alberta

Aligarh Muslim University

Satish Vedi is an author at Central Drug Research Institute specializing in immunology, infectious diseases, and vaccination.

Publications per year

2005–2019

12

Publications

12

Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models

Satish Vedi, Anil Dangi, Krishnan Hajela et al. · Vaccine · 2008 · 51 citations

, , +12

Improvement in the antifilarial efficacy of doxycycline and rifampicin by combination therapy and drug delivery approach

Anil Dangi, Varun Dwivedi, Satish Vedi et al. · Journal of drug targeting · 2009 · 24 citations

, , +14

Use of liposomized tetracycline in elimination of<i>Wolbachia</i>endobacterium of human lymphatic filariid<i>Brugia malayi</i>in a rodent model

Preeti Bajpai, Satish Vedi, Mohammad Owais et al. · Journal of drug targeting · 2005 · 24 citations

, , +17

Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine

Nancy Gupta, Saurabh Garg, Satish Vedi et al. · Frontiers in Immunology · 2018 · 23 citations · Full text

, , +17

Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis : Routes of immunization and TLR agonists critically impact vaccine’s efficacy

Nancy Gupta, Satish Vedi, Dennis Kunimoto et al. · Vaccine · 2016 · 22 citations

, , +14

1–5 of 12